Cancer cells sense 10 times farther than expected, offering clues on tumor spread

Researchers have found that cancer cells can probe their surrounding tissue far beyond the distances scientists previously thought possible. Clusters of normal epithelial cells, working together, can sense mechanical properties of their environment at distances up to 10 times greater than individual cells acting alone. The discovery directly addresses a question that has been central to cancer biology for decades: how do tumors identify and exploit paths through surrounding tissue before physically invading them?

What the research actually found

The study, published in Nature Physics, used a combination of traction force microscopy and computational modeling to map how groups of epithelial cells exert and sense mechanical forces in three-dimensional tissue matrices. Individual cells can sense stiffness gradients in the extracellular matrix at distances of roughly one to two cell diameters. Cell clusters, the research found, pool their mechanical sensing by coordinating force generation, which allows them to detect stiffness changes at distances of 10 to 20 cell diameters. That is a biologically significant gap.

The mechanism works because cells within a cluster transmit tension through their shared adhesion junctions, creating a larger composite mechanical antenna than any single cell could form independently. The cluster effectively reads the mechanical landscape ahead of it before sending any physical protrusion into that space. For tumors, this means a growing mass can identify regions of softer or more permeable tissue at a distance and redirect its expansion toward those regions before the leading edge of the tumor has physically arrived.

Why tumor spread has been so hard to explain until now

Cancer metastasis follows patterns that did not fit neatly into earlier models. Tumors reliably spread to specific secondary sites, and they navigate through dense tissue in ways that suggested some form of advance reconnaissance rather than random diffusion. Breast cancer, for example, spreads preferentially to bone, liver, and lung, and the routes it takes through surrounding tissue are not random. The question of what guides this movement at the cellular level has been one of the harder problems in oncology.

Prior research established that cells respond to mechanical cues, a process called mechanosensing, and that tumor cells tend to move toward stiffer regions of tissue, a phenomenon called durotaxis. But the range over which individual cells could detect those stiffness gradients was too short to explain the directed movement observed in actual tumors, which navigate distances many times larger than what individual cell sensing could account for. The new findings on collective long-range sensing close that explanatory gap.

The therapeutic target this discovery opens up

If cell clusters use coordinated mechanical force transmission to sense distant tissue properties, the junctions and signaling pathways that enable that coordination become potential therapeutic targets. The proteins responsible for mechanical coupling between cells in a cluster include E-cadherin, which mediates cell-cell adhesion, and the actin cytoskeleton components that transmit tension across those junctions. Several existing drug candidates already under investigation for other cancer applications affect these pathways.

The research team, based at the Institute for Bioengineering of Catalonia in Barcelona, noted that disrupting collective mechanical sensing would need to be targeted carefully to avoid interfering with normal tissue maintenance, since epithelial cell clusters throughout the body use similar coordination for routine functions like wound healing. That selectivity problem is common in cancer drug development and will require identifying molecular differences between normal and cancerous cell cluster mechanics before a therapeutically viable approach can be designed.

What this means for how researchers study metastasis

Most laboratory models of cancer invasion use two-dimensional cell culture systems or simplistic gel matrices that do not replicate the mechanical complexity of real tissue. The new findings were generated using three-dimensional tissue-like matrices specifically engineered to match the stiffness gradient properties of human breast and colon tissue, two cancer types where metastatic spread patterns have been particularly well documented clinically. That methodological detail matters because it means the sensing distances observed are likely to reflect what happens in actual patients rather than being an artifact of an oversimplified experimental setup.

The next planned phase of this research involves mapping collective sensing behavior in patient-derived tumor organoids, three-dimensional mini-tumor structures grown from biopsied cancer cells that preserve the genetic and mechanical characteristics of the original tumor. If the 10-fold sensing range observed in normal epithelial clusters also appears in cancer cell clusters derived from patients with known metastatic disease, it would provide direct clinical evidence linking this mechanism to real-world spread patterns. Those experiments are expected to be completed by late 2026.